# FDA Inspection 1303232 - Biomat USA, Incorporated - February 18, 2026

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/7fa8d789-dfde-4933-9618-63ff88ef8f19
Source feed: FDA_Inspections

> FDA Inspection 1303232 for Biomat USA, Incorporated on February 18, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1303232
- Company Name: Biomat USA, Incorporated
- Inspection Date: 2026-02-18
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Denver District Office

## Related Documents

- [FDA Inspection 1049076 - 2018-04-12](https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/8b07b549-ab95-4adb-a6bf-1db18ed36229)
- [FDA Inspection 981004 - 2016-06-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-incorporated/71486ad2-49f3-4c5f-bcbe-5d76051787df)

Company: https://www.keypedia.com/companies/biomat-usa-incorporated/757527b1-1bb4-4399-8604-7d57669ceccb

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face